$WUXI APPTEC (02359.HK)$ The main business is the global bio...
$WUXI APPTEC(02359.HK$ The main business is the global biopharmaceutical industry, providing integrated, end-to-end new drug R&D and manufacturing services. According to the 2021 report, sales revenue of $229 billion increased by 38.5% year-on-year, and net profit of $50 billion, up 72.2% year-on-year. The results showed growth in many industry chains after Mincang dropped its account in Wenjiang. Xiu's chain enterprises have also come to the fore. Last month, Wenjiang District signed a strategic cooperation agreement with Chengdu High-tech District, which will focus on the “three best practices” to jointly build a biopharmaceutical industry ecosystem across regions, plan to build adjacent cooperation zones, and explore the city A new paradigm for the joint development of the new district and the downtown area. Short-term stress note 120, post market is currently relatively healthy, participation price HK$110
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Peter YCS : US stocks rose, Hong Kong Hang Seng fell, US stocks fell, and Hang Seng also fell...
Peter YCS : Yao Ming started diving again today